Greenwich Wealth Management LLC boosted its position in shares of Lumos Pharma, Inc. (NASDAQ:LUMO – Free Report) by 55.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 76,341 shares of the company’s stock after acquiring an additional 27,339 shares during the period. Greenwich […]
Greenwich Wealth Management LLC lifted its stake in Lumos Pharma, Inc. (NASDAQ:LUMO – Free Report) by 55.8% in the third quarter, Holdings Channel.com reports. The firm owned 76,341 shares of the company’s stock after acquiring an additional 27,339 shares during the quarter. Greenwich Wealth Management LLC’s holdings in Lumos Pharma were worth $252,000 as of […]
Lumos Pharma (NASDAQ:LUMO – Get Free Report) had its price objective cut by research analysts at Oppenheimer from $17.00 to $16.00 in a research report issued on Monday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s target price indicates a potential upside of 451.72% from the stock’s previous close. LUMO […]